APA (7th ed.) Citation

B, B., S, B., N, W., J, M., C, A., S, R., . . . B, B. (2026). Antiphospholipid Antibodies and Atrial Fibrillation: Clinical Implications and the TaPL AF Study Design. Thrombosis and haemostasis. https://doi.org/10.1055/a-2899-3848

Chicago Style (17th ed.) Citation

B, Bacare, et al. "Antiphospholipid Antibodies and Atrial Fibrillation: Clinical Implications and the TaPL AF Study Design." Thrombosis and Haemostasis 2026. https://doi.org/10.1055/a-2899-3848.

MLA (9th ed.) Citation

B, Bacare, et al. "Antiphospholipid Antibodies and Atrial Fibrillation: Clinical Implications and the TaPL AF Study Design." Thrombosis and Haemostasis, 2026, https://doi.org/10.1055/a-2899-3848.